Pfizer seeks to expand omicron booster to 5- to 11-year-olds
Pfizer is asking the Food and Drug Administration to expand use of its updated COVID-19 booster shot to children ages 5 to 11
By The Associated Press
Published - Sep 26, 2022, 09:42 AM ET
Last Updated - Jun 24, 2023, 07:10 AM EDT
Pfizer asked U.S. regulators Monday to expand use of its updated COVID-19 booster shot to children ages 5 to 11.
Elementary school-aged children already received kid-sized doses of Pfizer’s original vaccine, a third of the dose given to everyone 12 and older -- two primary shots plus a booster.
If the Food and Drug Administration agrees, they would start getting a kid-sized dose of the new omicron-targeted formula when it was time for their booster.
FDA vaccine chief Dr. Peter Marks said last week he expected a decision on boosters for that age group soon.
